New Comprehensive Report on Preimplantation Genetic Diagnosis Market to Witness an Outstanding Growth during 2015 – 2023

The Asia preimplantation genetic diagnosis market has a highly competitive vendor landscape, observes Transparency Market Research (TMR). The market players are on a quest to increase their profit margins, which has brought them neck and neck in the race for market share. The competition is expected to further intensify over the coming years as the leading players resort to a range of strategies to establish their worth in the minds of the consumers. Furthermore, the market is highly fragmented on account of a large host of small-. Medium-, and large-scale service providers in the market. Perkin Elmer Inc., Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche, Natera Inc., and Abbott Laboratories are some of the key players operating in the Asian market.

preimplantation-genetic-diagnosis-market

Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9989

The estimates outlined by the researchers at Transparency Market Research (TMR) reveal that the market for preimplantation genetic diagnosis in Asia would grow at a CAGR of 6.80% over the period from 2015 to 2023. The market was valued at US$16.0 mn in 2014 and is projected to touch a value of US$28.8 mn by the end of 2023. East Asia registered a high growth rate over the past years with a total opportunity worth US$ 6.0 mn in 2014.

Growing Medical Tourism to be Beneficial for Growth

Vitro-fertilization has emerged as a key reproductive procedure in Asia, which has given a boost to the demand within the regional market for preimplantation genetic diagnosis. Medical tourism has emerged as a key trend across the entire world, and Asia has become the prime destination to travel for globally-reckoned medical experts. This has played a major role in propelling demand within the Asian market for preimplantation genetic diagnosis.

Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=9989

Rising awareness about genetic disorders has persuaded the masses to resort to preimplantation genetic diagnosis, which has enhanced the growth of the regional market. Single gene disorder screening has replaced prenatal diagnostic testing due to the proven advantages of the former. Thereby, the Asian market is reaping commendable benefits from multiple avenues within the medical and healthcare sector.

Economic Advantage of Treatment to Bolster Demand

The healthcare industry in Asia has attracted a large host of patients from across the globe because of dual reasons. Primarily, the skill and proficiency of the medical practitioners in India and China has resulted in a greater success rate of medical treatments. Secondly, the costs of treatments in Asia are relatively lower than the rates in developed regions. It can be safely estimated that the market in Asia would tread along an immensely lucrative growth path over the course of the coming years.

This information is from the new report by TMR, titled “Transformer Oil Market (Test Type – PGD for Aneuploidy Screening, PGD for Chromosomal Aberrations, PGD for Gender Selection, PGD for HLA Typing, PGD for Single Gene Disorder, and PGD for X-linked diseases; End-user – Fertility Clinics, Health Care Facilities (including hospitals, diagnostic centers, and health care facilities), and Academic Institutes and Research Centers) – Global Industry Analysis Size Share Growth Trends and Forecast 2016 – 2024.”

Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

The Asian market for preimplantation genetic diagnosis has been segmented as presented:

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Test Type

  • PGD for Aneuploidy Screening
  • PGD for Chromosomal Aberrations
  • PGD for Gender Selection
  • PGD for HLA Typing
  • PGD for Single Gene Disorder
  • PGD for X-linked diseases

Asia Preimplantation Genetic Diagnosis (PGD) Market, by End-user

  • Fertility Clinics
  • Health Care Facilities (including hospitals, diagnostic centers, and health care facilities)
  • Academic Institutes and Research Centers

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Geography

  • South Eastern Asia
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Rest of SEA
  • Eastern Asia
    • China
    • Japan
    • South Korea
    • Rest of Eastern Asia
  • Southern Asia
    • India
    • Sri Lanka
    • Rest of Southern Asia
  • Central Asia
  • Western Asia
    • Israel
    • Turkey
    • Jordan
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Western Asia

More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/global-chronic-obstructive-pulmonary-disease-copd-treatment-market-to-reach-us-26-2-bn-in-2027-drug-makers-focus-on-combination-therapies-transparency-market-research-301011476.html

2.  https://www.biospace.com/article/dna-test-kits-market-increase-in-demand-for-ancestry-testing-to-drive-market/

Previous post Benefits of Same-day delivery:
Next post Electrosurgical Devices Market share forecast to witness considerable growth from 2016 – 2024 | By Top Leading Vendors